{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":27,"n_cols":5,"rows_kept":27,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[15,2,15,3],[18,2,18,3],[18,4,18,5],[19,2,19,3],[19,4,19,5],[20,2,20,3],[21,2,21,3],[22,2,22,3],[24,2,24,3],[25,2,25,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910465455503321"]
[null,null,"Autore",null,"Yuan Jason X-J"]
[null,null,"Titolo",null,"Advances in the Management of Pulmonary Arterial Hypertension [[electronic resource]]"]
[null,null,"Pubbl/distr/stampa",null,"London, : Future Medicine Ltd, 2013"]
[null,null,"ISBN",null,"1-78084-309-7"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (129 p.)"]
[null,null,"Disciplina",null,"616.1/32"]
[null,null,"Soggetti",null,"Pulmonary hypertension -- Treatment"]
[{"$nulls":4},"Pulmonary hypertension"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"Title page; Copyright page; Contents; Foreword. Current therapies for the treatment of pulmonary arterial hypertension; 1. Etiology and prevalence of pulmonary arterial hypertension; 2. Pathology and diagnosis of pulmonary arterial hypertension; 3. Conventional therapy; 4. Targeted therapies: prostaglandins; 5. Targeted therapies: endothelin receptor antagonists ; 6. Stimulators and activators of soluble guanylate cyclase: potential therapeutic indications; 7. Surgical approaches in pulmonary arterial hypertension; 8. Monitoring and prognosis of pulmonary arterial hypertension"]
[{"$nulls":4},"9. Right ventricular failureIndex"]
[null,null,null,"Sommario/riassunto","Advances in the Management of Pulmonary Arterial Hypertension"]
[null,"2.","Record Nr.",null,"UNICAMPANIAVAN00109362"]
[null,null,"Titolo",null,"161482.01.RE : [Polimeri] / Gaetano Rossini S.r.l"]
[null,null,"Pubbl/distr/stampa",null,"1 campione di materiale"]
[null,null,"Descrizione fisica",null,"Costa Masnaga (LC), Italy : Gaetano Rossini S.r.l."]
[null,null,"Soggetti",null,"Polimeri"]
[{"$nulls":4},"Tessuti"]
[null,null,"Lingua di pubblicazione",null,"nessun linguaggio"]
[null,null,"Formato",null,"Oggetto"]
[null,null,null,"Livello bibliografico","Monografia"]